Jennifer Malin

563 total citations
18 papers, 409 citations indexed

About

Jennifer Malin is a scholar working on Economics and Econometrics, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jennifer Malin has authored 18 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 6 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jennifer Malin's work include Economic and Financial Impacts of Cancer (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Global Cancer Incidence and Screening (3 papers). Jennifer Malin is often cited by papers focused on Economic and Financial Impacts of Cancer (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Global Cancer Incidence and Screening (3 papers). Jennifer Malin collaborates with scholars based in United States and Australia. Jennifer Malin's co-authors include Jane C. Weeks, Michael Steinberg, John Adams, Mark S. Litwin, Angel M. Cronin, Aileen B. Chen, Deborah Schrag, James A. Hayman, Benjamin A. Spencer and Elizabeth A. Chrischilles and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Medical Decision Making.

In The Last Decade

Jennifer Malin

16 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Malin United States 9 174 137 121 116 93 18 409
Fadila Farsi France 13 192 1.1× 175 1.3× 91 0.8× 114 1.0× 84 0.9× 40 526
Joan Prades Spain 8 229 1.3× 103 0.8× 87 0.7× 97 0.8× 68 0.7× 21 458
Yueh‐Hsin Wang Taiwan 13 260 1.5× 122 0.9× 59 0.5× 60 0.5× 92 1.0× 24 540
Ramsankar Basak United States 13 163 0.9× 376 2.7× 98 0.8× 109 0.9× 122 1.3× 52 700
Vinit Nalawade United States 14 184 1.1× 193 1.4× 47 0.4× 130 1.1× 105 1.1× 54 533
T. Lizée France 7 306 1.8× 154 1.1× 62 0.5× 146 1.3× 41 0.4× 16 526
P. Trémolières France 6 309 1.8× 116 0.8× 62 0.5× 146 1.3× 33 0.4× 15 466
Joseph Lipscomb United States 8 286 1.6× 109 0.8× 142 1.2× 94 0.8× 82 0.9× 16 534
Anthony Arnold Australia 9 161 0.9× 62 0.5× 41 0.3× 97 0.8× 52 0.6× 15 387
Jeremy B. Shelton United States 13 189 1.1× 169 1.2× 100 0.8× 126 1.1× 104 1.1× 40 555

Countries citing papers authored by Jennifer Malin

Since Specialization
Citations

This map shows the geographic impact of Jennifer Malin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Malin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Malin more than expected).

Fields of papers citing papers by Jennifer Malin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Malin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Malin. The network helps show where Jennifer Malin may publish in the future.

Co-authorship network of co-authors of Jennifer Malin

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Malin. A scholar is included among the top collaborators of Jennifer Malin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Malin. Jennifer Malin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Byfield, Stacey DaCosta, et al.. (2020). Real-World Outcomes and Value of First-Line Therapy for Metastatic Non-Small Cell Lung Cancer†. Cancer Investigation. 38(10). 608–617. 2 indexed citations
2.
Shapiro, Martin F., et al.. (2017). Physician variation in lung cancer treatment at the end of life.. PubMed. 23(4). 216–223. 8 indexed citations
3.
Clarke, Christina A., Steven M. Asch, Laurence C. Baker, et al.. (2016). Public Reporting of Hospital-Level Cancer Surgical Volumes in California: An Opportunity to Inform Decision Making and Improve Quality. Journal of Oncology Practice. 12(10). e944–e948. 6 indexed citations
4.
Tisnado, Diana M., Jennifer Malin, Katherine L. Kahn, et al.. (2016). Variations in Oncologist Recommendations for Chemotherapy for Stage IV Lung Cancer: What Is the Role of Performance Status?. Journal of Oncology Practice. 12(7). 653–662. 9 indexed citations
5.
Ettinger, David S., Michael Kuettel, Jennifer Malin, et al.. (2015). NCCN Roundtable: What Are the Characteristics of an Optimal Clinical Practice Guideline?. Journal of the National Comprehensive Cancer Network. 13(5S). 640–642. 8 indexed citations
6.
Tramontano, Angela C., Jennifer Malin, M Miller, et al.. (2015). Catalog and Comparison of Societal Preferences (Utilities) for Lung Cancer Health States. Medical Decision Making. 35(3). 371–387. 29 indexed citations
7.
Bach, Peter B., et al.. (2015). NCCN Roundtable:Value-Based Decision-Making at the Bedside. Journal of the National Comprehensive Cancer Network. 13(5S). 659–661. 3 indexed citations
8.
Hornbrook, Mark C., Jennifer Malin, Jane C. Weeks, et al.. (2014). Did Changes in Drug Reimbursement After the Medicare Modernization Act Affect Chemotherapy Prescribing?. Journal of Clinical Oncology. 32(36). 4042–4049. 11 indexed citations
9.
Shelton, Jeremy B., Ted A. Skolarus, Diana L. Ordin, et al.. (2014). Validating electronic cancer quality measures at Veterans Health Administration.. PubMed. 20(12). 1041–7. 9 indexed citations
10.
Chen, Aileen B., Angel M. Cronin, Jane C. Weeks, et al.. (2013). Expectations About the Effectiveness of Radiation Therapy Among Patients With Incurable Lung Cancer. Journal of Clinical Oncology. 31(21). 2730–2735. 81 indexed citations
11.
Chen, Aileen B., Angel M. Cronin, Jane C. Weeks, et al.. (2013). Palliative Radiation Therapy Practice in Patients With Metastatic Non–Small-Cell Lung Cancer: A Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. Journal of Clinical Oncology. 31(5). 558–564. 61 indexed citations
12.
Liu, Zhimei, et al.. (2009). The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK. Applied Health Economics and Health Policy. 7(3). 193–205. 38 indexed citations
13.
Slamon, DJ, Linnea Chap, Sophia K. Apple, et al.. (2005). Neoadjuvant docetaxel (T), carboplatin (C), with or without trastuzumab (H) for T3 and T4 breast cancer. Journal of Clinical Oncology. 23(16_suppl). 845–845. 1 indexed citations
14.
Spencer, Benjamin A., Michael Steinberg, Jennifer Malin, John Adams, & Mark S. Litwin. (2003). Quality-of-Care Indicators for Early-Stage Prostate Cancer. Journal of Clinical Oncology. 21(10). 1928–1936. 98 indexed citations
15.
Halbert, Ronald J., Carol Zaher, Sally Wade, et al.. (2002). Outpatient cancer drug costs. Cancer. 94(4). 1142–1150. 1 indexed citations
16.
Litwin, Mark S., Michael Steinberg, Jennifer Malin, et al.. (2000). Prostate Cancer Patient Outcomes and Choice of Providers: Development of an Infrastructure for Quality Assessment. RAND Corporation eBooks. 36 indexed citations
17.
Litwin, Mark S., Michael Steinberg, Jennifer Malin, et al.. (2000). Measuring Quality of Care for Prostate Cancer. RAND Corporation eBooks. 1 indexed citations
18.
Malin, Jennifer, et al.. (1993). Arthropathy and HIV infection. Postgraduate Medicine. 93(8). 143–150. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fadila Farsi Breakdown of academic impact, for papers by Joan Prades Breakdown of academic impact, for papers by Yueh‐Hsin Wang Breakdown of academic impact, for papers by Ramsankar Basak Breakdown of academic impact, for papers by Vinit Nalawade Breakdown of academic impact, for papers by T. Lizée Breakdown of academic impact, for papers by P. Trémolières Breakdown of academic impact, for papers by Joseph Lipscomb Breakdown of academic impact, for papers by Anthony Arnold Breakdown of academic impact, for papers by Jeremy B. Shelton
Rankless by CCL
2026